Science in Sport plc
("Company" or "Group")
Director/PDMR Shareholding
Science in Sport plc (AIM: SIS), the premium performance nutrition company serving elite athletes, sports enthusiasts and the gym lifestyle community, announces that it has been notified of the following transaction by a PDMR.
| Notification of a Transaction pursuant to Article 19(1) of the EU Market Abuse Regulation (EU) No. 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. | | ||||||||||||
| 1 | Details of the person discharging managerial responsibilities/person closely associated | | |||||||||||
| a. | Name | Lombard Odier Asset Management (Europe) Limited
| | ||||||||||
| 2 | Reason for notification
| | |||||||||||
| a. | Position/Status | PCA of Henry Turcan, Non-Executive Director
| | ||||||||||
| b. | Initial notification/ Amendment | Initial Notification | | ||||||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | | |||||||||||
| a. | Name | Science In Sport plc | | ||||||||||
| b. | LEI | 213800FWYWBJFJPPJ981 | | ||||||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | | |||||||||||
| a. | Description of the financial instrument, type of instrument | Ordinary Shares of 10 pence each GB00BBPV5329 | | ||||||||||
| b. | Nature of the transaction | Purchase of Ordinary Shares | | ||||||||||
| c. | Price(s) and volume(s) |
| | ||||||||||
| d. | Aggregated information - Aggregated Volume - Price |
N/A |
| ||||||||||
| e. | Date of the transaction | 4 July 2023 | | ||||||||||
| f. | Place of the transaction | Outside a trading venue | | ||||||||||
| | | | | | | | | | | ||||
| | | | | | | | | | | ||||
For further information, please contact:
| Science in Sport plc | T: 020 7400 3700 |
| Stephen Moon, CEO | |
| Dan Lampard, CFO | |
| | |
| Liberum (Nominated adviser and broker) | T: 020 3100 2000 |
| Richard Lindley Will Hall | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.